Advocacy intelligence hub — real-time data for patient organizations
Vanda Pharmaceuticals — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
HETLIOZ
Vanda Pharmaceuticals, Inc.
HETLIOZ
(tasimelteon)Orphan drugstandardVanda Pharmaceuticals, Inc.
Melatonin Receptor Agonist [EPC]
12.1 Mechanism of Action The mechanism by which tasimelteon exerts its therapeutic effect in patients with Non-24 or nighttime sleep disturbances in S...